incorporating immunotherapy in the frontline & salvage treatment of hodgkin lymphoma
Published 1 year ago • 148 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
1:43
the addition of immunotherapy to the front-line treatment of as hodgkin lymphoma
-
1:47
advances in hodgkin lymphoma treatment: moving away from abvd and beacopp
-
1:03
incorporating immunotherapy into the first-line treatment of all
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
1:09
novel immunotherapy combinations in hodgkin lymphoma
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
1:12:46
immunotherapy treatment and survivorship: precision medicine in action
-
14:09
understanding immunotherapy
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:09:24
update on immunotherapy in the treatment of lymphoma | lrf webinars
-
1:45
the role of non-covalent btkis in the era of covalent btkis for b-cell malignancies
-
1:57
the current hodgkin lymphoma immunotherapy landscape
-
2:33
transplantation in hodgkin lymphoma in the context of targeted immunotherapy
-
2:03
novel therapeutic agents in the treatment of hodgkin and non-hodgkin lymphoma
-
2:11
pirtobrutinib as a bridge to car-t therapy in b-cell malignancies
-
1:36
the changing role of chemotherapy in lymphoma and the value of novel immunotherapies
-
3:47
the role of immunotherapy in the aml treatment landscape
-
5:15
the promise of immunotherapies in t-cell lymphoma
-
1:52
impact of immunotherapy on lymphoma
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
1:18
advances in immunotherapy for lymphoma